The stock's fall snapped a two-day winning streak.

Analysts have recently evaluated CME Group and provided 12-month price targets. The average target is $253.17, accompanied by a high estimate of $287.00 and a low estimate of $212.00. This upward ...

CME shares have delivered market-beating returns over the past two years, prompting the question of whether it's time to lock ...

CME Group is the IBD Stock Of The Day for Monday ... The RS line, which tracks a stock's performance vs. the S&P 500, had been trending lower for nearly five years. CME stock has a 21-day ATR ...

In this article, we are going to take a look at where CME Group Inc. (NASDAQ ... by below-average market performance. Many ...

CME Group is a top choice for income investors with strong cash flow, high dividends, and a scalable model offering ...

The company’s strong performance is reflected ... though InvestingPro analysis indicates the stock is currently trading slightly above its Fair Value. CME Group, known for its diverse risk ...

Investing.com -- Raymond James upgraded CME Group Inc (NASDAQ ... ability to benefit from ongoing market uncertainty, makes its stock an attractive investment opportunity.

CME Group (CME) announced plans to launch Bloomberg Commodity Subindex futures on March 31, pending regulatory review. BCOM Subindex futures will be available across seven leading commodity index ...

The company’s strong performance is reflected in its impressive ... though InvestingPro analysis indicates the stock is currently trading slightly above its Fair Value. CME Group, known for its ...